Researchers combine gene therapy with optogenetics to curb abnormal neural activity and prevent seizure-like activity in neurons.

Shares of several COVID-19 vaccine developers sank fast enough to reflect investor jitters about vaccine policy given RFK’s ...

Results of research in mice may provide potential avenues for therapeutic interventions in stress-related disorders.

The BiaB advantages over traditional methods of RNA manufacturing, include high throughput of high-quality pharmaceutical ...

The amino acid glutamine plays an unexpected role in erythropoiesis, the differentiation of erythroid progenitor cells into ...

New ML model shows importance of microbial load, as opposed to the more often used microbial composition, as a metric in ...

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Innovative drug development "the flavor of 2025" says Ali Pashazadeh, who discusses how the new administration will likely ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

GEN webinar, experts from AbbVie and Benchling will share insights into the current tech landscape, AI readiness, and the ...